atorvastatin has been researched along with Cholangiocarcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akahane, T; Kaji, K; Kitagawa, K; Mitoro, A; Moriya, K; Namisaki, T; Nishimura, N; Saikawa, S; Sato, S; Yoshiji, H | 1 |
| Buranrat, B; Kukongviriyapan, V; Prawan, A; Senggunprai, L | 1 |
| Chayama, K; Inoue, M; Ishigaki, T; Ishii, Y; Itsuki, H; Kamigaki, M; Kobayashi, K; Kosaka, K; Minami, T; Okazaki, A; Sasaki, T; Serikawa, M; Yukutake, M | 1 |
3 other study(ies) available for atorvastatin and Cholangiocarcinoma
| Article | Year |
|---|---|
Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.
Topics: Animals; Anticholesteremic Agents; Antimetabolites, Antineoplastic; Apoptosis; Atorvastatin; Bile Duct Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Connective Tissue Growth Factor; Contractile Proteins; Cysteine-Rich Protein 61; Deoxycytidine; Drug Combinations; Drug Interactions; Gemcitabine; Humans; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Muscle Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Nuclear Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-yes; Repressor Proteins | 2020 |
Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
Topics: Apoptosis; Atorvastatin; Bile Duct Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Reactive Oxygen Species; Simvastatin | 2016 |
Statins induce apoptosis and inhibit proliferation in cholangiocarcinoma cells.
Topics: Apoptosis; Atorvastatin; Caspase 3; Cell Cycle; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Cholangiocarcinoma; Extracellular Signal-Regulated MAP Kinases; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neoplastic Stem Cells; Pyrroles; Quinolines | 2011 |